Brand Name | Status | Last Update |
---|---|---|
bortezomib | ANDA | 2023-12-29 |
velcade | New Drug Application | 2022-10-25 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
mantle-cell lymphoma | — | D020522 | C83.1 |
multiple myeloma | — | D009101 | C90.0 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple myeloma | D009101 | — | C90.0 | 134 | 268 | 97 | 14 | 54 | 499 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 14 | 13 | 4 | 1 | 3 | 32 |
Waldenstrom macroglobulinemia | D008258 | HP_0005508 | C88.0 | 8 | 16 | 1 | 1 | 1 | 25 |
Immunoglobulin light-chain amyloidosis | D000075363 | — | — | 2 | 4 | 6 | 1 | 1 | 14 |
Hematologic neoplasms | D019337 | — | — | 6 | 5 | — | 2 | 3 | 12 |
Kidney transplantation | D016030 | — | — | 2 | 3 | 1 | 1 | — | 5 |
Chronic renal insufficiency | D051436 | — | N18 | — | 1 | — | 1 | — | 2 |
Residual neoplasm | D018365 | — | — | — | — | — | 1 | 1 | 2 |
Iga glomerulonephritis | D005922 | EFO_0004194 | — | — | — | — | 1 | 1 | 2 |
Healthy volunteers/patients | — | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Mantle-cell lymphoma | D020522 | — | C83.1 | 21 | 37 | 2 | — | 2 | 54 |
Lymphoma | D008223 | — | C85.9 | 22 | 30 | 1 | — | 1 | 49 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 20 | 19 | 1 | — | 2 | 37 |
Myeloid leukemia acute | D015470 | — | C92.0 | 15 | 10 | 1 | — | 2 | 25 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 10 | 12 | 2 | — | 1 | 22 |
Leukemia | D007938 | — | C95 | 11 | 8 | 1 | — | — | 18 |
Amyloidosis | D000686 | EFO_1001875 | E85 | 1 | 8 | 4 | — | 4 | 15 |
Peripheral nervous system diseases | D010523 | HP_0009830 | G64 | — | 2 | 1 | — | 3 | 6 |
Thrombocytopenic purpura idiopathic | D016553 | EFO_0007160 | D69.3 | — | 1 | 1 | — | — | 2 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | 1 | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 45 | 11 | — | — | 1 | 52 |
Follicular lymphoma | D008224 | — | C82 | 10 | 18 | — | — | 2 | 27 |
Plasma cell neoplasms | D054219 | — | — | 13 | 16 | — | — | — | 25 |
Non-small-cell lung carcinoma | D002289 | — | — | 7 | 16 | — | — | — | 21 |
Myelodysplastic syndromes | D009190 | — | D46 | 11 | 8 | — | — | 1 | 18 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 10 | 5 | — | — | 2 | 16 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 7 | 5 | — | — | 1 | 12 |
Hodgkin disease | D006689 | — | C81 | 7 | 5 | — | — | — | 12 |
B-cell lymphoma marginal zone | D018442 | — | C88.4 | 6 | 4 | — | — | 1 | 11 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 8 | 6 | — | — | — | 11 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Large-cell lymphoma anaplastic | D017728 | — | C84.6 | 5 | — | — | — | — | 5 |
Lymphomatoid granulomatosis | D008230 | — | C83.8 | 4 | — | — | — | 1 | 5 |
Large-cell lymphoma immunoblastic | D016400 | — | — | 3 | — | — | — | 1 | 4 |
Fallopian tube neoplasms | D005185 | — | — | 3 | — | — | — | — | 3 |
Anemia | D000740 | HP_0001903 | D64.9 | 2 | — | — | — | — | 2 |
Intraocular lymphoma | D064090 | — | — | 1 | — | — | — | 1 | 2 |
Astrocytoma | D001254 | EFO_0000271 | — | 2 | — | — | — | — | 2 |
Oligodendroglioma | D009837 | EFO_0000631 | — | 2 | — | — | — | — | 2 |
Castration-resistant prostatic neoplasms | D064129 | — | — | 1 | — | — | — | — | 1 |
Myelomonocytic leukemia chronic | D015477 | — | C93.1 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Heart failure | D006333 | HP_0001635 | I50 | — | — | — | — | 1 | 1 |
Hairy cell leukemia | D007943 | — | C91.4 | — | — | — | — | 1 | 1 |
Systolic heart failure | D054143 | EFO_1001207 | I50.20 | — | — | — | — | 1 | 1 |
Hemoglobin sc disease | D006450 | EFO_1001797 | D57.2 | — | — | — | — | 1 | 1 |
Glomerulonephritis | D005921 | HP_0000099 | N05 | — | — | — | — | 1 | 1 |
Membranoproliferative glomerulonephritis | D015432 | — | — | — | — | — | — | 1 | 1 |
Survivorship | D000073859 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Bortezomib |
INN | bortezomib |
Description | Bortezomib is l-Phenylalaninamide substituted at the amide nitrogen by a 1-(dihydroxyboranyl)-3-methylbutyl group and at N(alpha) by a pyrazin-2-ylcarbonyl group. It is a dipeptidyl boronic acid that reversibly inhibits the 26S proteasome. It has a role as an antineoplastic agent, a proteasome inhibitor, a protease inhibitor and an antiprotozoal drug. It is an amino acid amide, a member of pyrazines and a L-phenylalanine derivative. It is functionally related to a boronic acid. |
Classification | Small molecule |
Drug class | proteozome inhibitors |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O |
PDB | — |
CAS-ID | 179324-69-7 |
RxCUI | — |
ChEMBL ID | CHEMBL325041 |
ChEBI ID | 52717 |
PubChem CID | 387447 |
DrugBank | DB00188 |
UNII ID | 69G8BD63PP (ChemIDplus, GSRS) |